Deficiencies in serotonergic neurotransmission are involved in the pathophysiology of depression. Due to its modulatory effect on serotonin (5-HT) release, the 5-HT 1A -receptor is thought to play a decisive role in the therapy of this mood disorder. However, it is not fully understood how antidepressant effects are mediated by pre-and postsynaptic receptor sites. In this study we examined the impact of postsynaptic 5-HT 1A -receptor over-expression in corticolimbic areas of male and female mice on the performance in the forced swim-test (FST). Furthermore, we investigated their response to the serotonin selective reuptake inhibitor (SSRI) citalopram in comparison to the selective noradrenaline reuptake inhibitor reboxetine, as well as the partial 5-HT 1A -receptor agonists, buspirone and S 15535. Additionally, these drugs were evaluated in the open field-test in order to observe effects on motor activity. The density of 5-HT 1A -receptors in discrete corticolimbic regions was determined in detail by quantitative autoradiography with [ 3 H]8eOHeDPAT to investigate genotype as well as sex dependent differences in the expression pattern. [ 3 H]8eOHeDPAT binding differed depending on sex with female mice of both genotypes displaying higher receptor binding in distinct brain areas. In the FST untreated male but not female over-expressing (OE) mice showed an antidepressant-like behaviour compared to wild-type (WT) mice. Citalopram yielded an antidepressant effect without influencing locomotor activity in OE mice but not in WT mice. Reboxetine had no antidepressant-like effect in OE mice, but sex-dependently in WT mice. The two partial agonists, buspirone and S 15535 produced no antidepressant-like activity in both genotypes and sexes, but aberrant motor effects. The antidepressant-like phenotype of male transgenic mice accounts for an involvement of postsynaptic 5-HT 1A -receptors in the FST behaviour. In addition, the selective over-expression of postsynaptic 5-HT 1A -receptors in mice contributes to the antidepressant response to citalopram in the FST. Although further pharmacological analysis is required, the data provide novel support for a role of postsynaptic 5-HT 1A -receptors in the effects of SSRIs.
Introduction
The serotonin (5-HT) hypothesis of depression has been well established since the late 1960s. Particularly, deficits in serotonergic neurotransmission were found to play a key role in the pathophysiology of major depression, which has led to the development of selective serotonin reuptake inhibitors (SSRIs) (see review by Millan, 2006) . Several subtypes of the 5-HT-receptor family, which contains at least 14 members, have been associated with depressive disorders. Within this family the 5-HT 1A -receptor has gained increasing interest in the auxiliary therapy of depression. The 5-HT 1A -receptor stands out because of its appearance on pre-and postsynaptic sites and its modulatory effect on serotonergic neurotransmission. Presynaptic 5-HT 1A -autoreceptors are located in high densities somatodendritically in the raphe nuclei where they control via a negative feedback mechanism the firing rate of serotonergic neurons and therefore decrease 5-HT release into the synaptic cleft (Ago et al., 2003; Albert et al., 1990; Blier and de Montigny, 1990 ).
Postsynaptic 5-HT 1A -receptors are widely expressed as heteroreceptors on glutamatergic pyramidal cells and on GABAergic interneurons in the hippocampus, cortical regions, septum, amygdala, and hypothalamus (Chessell et al., 1993; Pompeiano et al., 1992; Wedzony et al., 2007) where their activation leads to decreased firing rates of the respective neurons (e.g. Blier and de Montigny, 1990; Sprouse and Aghajanian, 1988; Tanaka and North, 1993) .
The use of 5-HT 1A -receptor agonists for the treatment of depression has been widely discussed and is partially based on the results of receptor binding studies in humans: In suicidal victims and patients suffering from major depression an increased density of presynaptic 5-HT 1A -receptors was revealed (Boldrini et al., 2008; Stockmeier et al., 1998) and could be a reason for the diminished 5-HT-levels found post-mortem in depressed patients. The role of the 5-HT 1A -receptor in the pathophysiology of depression has been strengthened by the detection of the C(-1019)G 5-HT 1A -promoter polymorphism. This allele is widely spread in depressed patients and was linked to a higher 5-HT 1A -receptor binding in the raphe nuclei (Lemonde et al., 2003) . These two observations in humans suggested that drugs desensitising presynaptic 5-HT 1A -receptor sites could be beneficial for the therapy of depression, but monotherapy with partial 5-HT 1A -receptor agonists, like buspirone and tandospirone, showed only a weak antidepressant response (McGrath et al., 1994; Robinson et al., 1990; Stahl et al., 1998) . Partial agonists behave as full agonists at somatodendritic receptors and do not exert full agonist effects at postsynaptic 5-HT 1A -receptors (Savitz et al., 2009) , therefore they might not be sufficient for the therapy of depression. Preclinical data stand to reason that activation of postsynaptic 5-HT 1A -receptors, especially in the forebrain, is important for the antidepressant effect of 5-HT 1A -receptor agonists (see Blier and Ward, 2003 for review) . The relevance of postsynaptic 5-HT 1A -receptors for depression is supported by the novel agonist F15599 with high selectivity and efficacy at postsynaptic 5-HT 1A -receptors. F15599 revealed high antidepressant activity in respective animal models and thus promises to be an improvement in the therapy of depression Llado-Pelfort et al., 2010) .
In order to specify the role of the postsynaptic 5-HT 1A -receptor our group has developed a transgenic mouse line (OE mice) with a stable over-expression of the 5-HT 1A -receptor predominantly in the outer cortical layers and CA3 region of the hippocampus (Bert et al., 2006) . In a previous publication we were able to show that these transgenic mice respond with an exaggerated serotoninsyndrome to 8eOHeDPAT even at low doses (Bert et al., 2006) , an effect that is clearly postsynaptically mediated. In addition, 8eOHeDPAT induced anterograde amnesia in the inhibitory avoidance-test only in transgenic mice (Bert et al., 2009 ), a response which has also been associated to 5-HT 1A -heteroreceptor activation (Carli et al., 1992; Misane et al., 1998) . The lack of anxiolytic activity of 8eOHeDPAT in the elevated plus maze-test (Bert et al., 2006) underlines that in our transgenic mice the surplus receptors are postsynaptically expressed. All previous findings indicate that the over-expressed 5-HT 1A -receptors are pharmacologically active.
In the present study we examine the behaviour of OE and wildtype (WT) mice in the forced swim-test (FST) and their response to specific antidepressants with respect to genotype and sex specific differences. Firstly, we specified and quantified the 5-HT 1A -receptor over-expression by receptor-autoradiography with [ 3 H] labelled 8eOHeDPAT. Then we investigated the response of male and female WT and OE mice to the SSRI citalopram, which is highly selective for serotonin reuptake sites and has no secondary pharmacological action, and compared its effect to the effects of the selective noradrenaline reuptake inhibitor (NARI) reboxetine. Furthermore, we examined the effects of two partial 5-HT 1A -receptor agonists, buspirone and S 15535 in the FST. Compared to buspirone, S 15535 exhibits a very low intrinsic activity and has additionally a higher affinity to postsynaptic than to presynaptic 5-HT 1A -receptors (Newman-Tancredi et al., 1998a , 1998b . In order to identify genotype-related drug effects on motor activity (Cryan et al., 2005b) doses of substances that were effective in the FST were evaluated in the open field-test (OFT).
Methods

Animals
We used male and female transgenic mice (background: NMRI mice by HarlanWinkelmann, Borchen, Germany) with a stable over-expression of the 5-HT 1A -receptor as well as male and female NMRI wild-type mice at the age of 12e14 weeks (the generation of mice was previously described in detail (Bert et al., 2006) ). Mice were separately bred and group-housed by sex and genotype with 4e7 animals per cage (Makrolon type IV) under standard laboratory conditions (22 AE 2 C room temperature, 55 AE 10% humidity) with an artificial 12 h lightedark cycle (lights on 06.00e18.00 h). Animals had free access to food (Altromin 1326, Lage, Germany) and tap water. Experiments were performed in accordance with the guidelines of the German Animal Welfare Act and were approved by the Berlin State Authority ("Landesamt für Gesundheit und Soziales", G 0107/06, G 0165/08, A 0432/08).
In vitro autoradiography
Tissue preparation
Immediately after decapitation, the brains were rapidly removed, frozen on crushed dry ice and stored at À80 C until further use. Frontal brain slices (20 mm)
were cut with a microtome-cryostat (Leica, Bensheim, Germany), thaw-mounted onto glass slides, air-dried for 120 min, and stored at À20 C. Slices for 5-HT 1A -receptor analysis were determined based on the mouse brain atlas of Franklin and Paxinos (1997) . Three different planes were used (see Fig. 1 ). Specific [ 3 H] 8eOHeDPAT binding was analysed in the following brain regions: Plane 1 (bregma: þ1.54 mm): frontoparietal and piriform cortex, tenia tecta, lateral septum, and claustrum/endopiriform nucleus; plane 2 (bregma: À2.18 mm): retrosplenial and parietal cortex, the anterior hippocampus (CA1, CA2, CA3, and dentate gyrus), amygdala (medial, basal/lateral, and cortical), and hypothalamus; plane 3 (bregma: À4.36 mm): dorsal raphe nucleus (DRN) and median raphe nucleus (MRN).
Incubation and data analysis
5-HT 1A -receptor autoradiography was performed as described by Schiller et al. (2003) . The tritium [ 3 H] labelled 5-HT 1A -receptor agonist 8eOHeDPAT (Perkin Elmer, Rodgau-Jügesheim, Germany) was used in a concentration of 2 nM.
Nonspecific binding was determined on adjacent slices in the presence of 10 mM MM 77 (1-(2-Methoxyphenyl)-4-[(4-succinimido)butyl]-piperazine, a 5-HT 1A -receptor antagonist; Biotrend, Cologne, Germany). The glass slides were pre-incubated in 50 mM TriseHCl (pH 7.4) containing 120 mM NaCl and 4 mM CaCl 2 for 15 min at room temperature (RT). The next step was the main incubation (50 mM TriseHCl, 60 min, RT) in order to assess total (only radioligand) and nonspecific (radioligand þ displacer) binding. After incubation, all slides were washed twice for 10 min in ice-cold pre-incubation buffer and briefly dipped into distilled water. Finally, the slides were dried in a stream of cold air. In order to avoid procedural bias, comparative brain slices of all groups were incubated simultaneously. All slides were exposed to [ days. Afterwards, the imaging plates were scanned with a bioimaging analyser (Fuji, Japan) and evaluated using the software AIDA 2.11 (Raytest, Straubenhardt, Germany). The specific binding of [ 3 H]8eOHeDPAT was calculated and displayed in fmol/mg protein. Nissl-stained reference slices, adjacent to the sections which had been processed for autoradiography, were used to identify brain regions. All bilaterally localised brain regions were analysed separately on the left and on the right hemisphere (cortical and hippocampal regions as well as the claustrum/endopiriform nucleus and the different amygdaloid nuclei). No significant difference in [ 3 H] 8eOHeDPAT-specific binding was observed between left and right hemisphere in the different brain regions that were analysed. Therefore, the values from the left and right hemisphere of 6 mice per group were summarised as one mean (n ¼ 12). All regions located at the midline of the brain were analysed as a whole region (i.e., tenia tecta, lateral septum, hypothalamus, DRN, and MRN). The mean [ 3 H] 8eOHeDPAT binding for each of these brain regions was calculated based on a maximum of 6 single values in each group (n ¼ 6). Data could not be evaluated in some cases as the brain tissue was destroyed during incubation or the slice used for incubation did not entirely match the brain plane necessary for quantitative densitometry. Therefore, the means for each group were calculated from values of 4e6 animals (Table 1) .
Behavioural experiments
All behavioural experiments were conducted in a sound-attenuated chamber between (8.30 and 12.00 a.m.). The animals were moved into an anteroom at least 1 h before the start of the experiment. Between 6 and 13 animals were used per group (group sizes are indicated in the figures). A new cohort of animals was used for each experiment and treatment.
Forced swim-test (FST)
According to Porsolt et al. (1978) animals were lowered into a 5 l glass-beaker (Ø 19 cm) filled with warm water (24 C) to a height of 15 cm. Their behaviour was observed for 6 min. The time animals spent floating on the water surface without any movement, except for minimal activity which kept them from drowning, was recorded. This behaviour is defined as "behavioural despair" and is decreased by the administration of antidepressants. The immobility time [s] was measured manually using a computerised tracking system (TSE VideoMot, Version 1.43, Bad Homburg, Germany).
Open field-test (OFT)
The OFT was conducted in order to evaluate differences in drug effects on motor activity of both the genotypes that could interfere with the behaviour in the FST. Therefore, doses that were effective in the FST were tested in the OFT. The open field (50 cm Â 50 cm Â 30 cm) consisted of white painted wood. The floor was covered with a black mat to avoid aversiveness. A halogen lamp provided the same light intensity as in the animal facilities (approximately 250 lx in the centre). The animals were initially placed in the centre of the open field. Their ambulatory behaviour was recorded for 10 min and total distance [m] was measured using a computer-based system (VideoMot2, TSE Systems, Bad Homburg, Germany).
Drugs
Citalopram, buspirone (both Tocris, Avonmouth, UK), and reboxetine (generous donation from Pfizer, Groton, USA) were freshly dissolved in physiological saline solution. S 15535 (generous donation from Servier, Croissy/Seine, France) was freshly dissolved in sterile distilled water. All drug solutions and vehicle (saline or distilled water) were injected intraperitoneally (i.p.) with a volume of 10 ml/kg 30 min before testing.
Statistics
Values are presented as means and standard errors of the mean (SEM). Graphs were created using SigmaPlot 11.0 software. Data was analysed with SigmaStat 3.0 software programme. All data were tested for normal distribution with the H]8eOHeDPAT binding in male and female wild-type (WT) and over-expressing mice (OE) and Nissl-stained mice brain slices of the anatomical planes that were used. Plane 1: bregma: þ1.54 mm, plane 2: bregma: À2.18 mm, plane 3: bregma: À4.36 mm. 5-HT 1A -receptor binding is illustrated by increasing intensity in yellow to red colour. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) ShapiroeWilk method. The majority of data was not normally distributed and was therefore analysed with non-parametric tests. ManneWhitney-U-tests or KruskalleWallis ANOVAs were used for the behavioural data in order to compare two or more groups, respectively. Dunn's tests were conducted for post-hoc comparison versus control, e.g. WT or vehicle, respectively. A probability value of p < 0.05 was considered to be statistically significant. Data from the 5-HT 1A -receptor autoradiography was analysed by using the ManneWhitney-U-tests; following Bonferroni correction, p was defined as <0.0125.
Results
Receptor-autoradiography with [ 3 H]8eOHeDPAT
Representative sample slices of [ 3 H]8eOHeDPAT binding of male and female WT and OE mice are shown in Fig. 1 .
OE vs. WT mice
Male OE mice display significantly higher 5-HT 1A -receptor binding in all investigated cortical areas (from 2.5-fold for the piriform cortex to 9-fold for the parietal cortex) in comparison to male WT mice (see Table 1 ). In the CA3 region of the hippocampus [ 3 H]8eOHeDPAT binding was exceedingly higher (6-fold) in male OE mice than in males WT mice. In the sub-regions of the amygdala, hypothalamus, claustrum/endopiriform nucleus, and tenia tecta 5-HT 1A -receptor binding was 1.5e3.5-fold increased in male OE mice. We did not detect differences in [
3 H]8eOHeDPAT binding between male OE and male WT mice in the DRN and MRN (see Table 1 ). In general, the level and distribution pattern of over-expressed 5-HT 1A -receptors were similar in female and male OE mice, except for the additional over-expression in the CA2 region of the hippocampus of female OE mice (see Table 1 ).
Male vs. female mice
Sex differences were detected in distinct brain regions of WT as well as OE mice. Female WT mice showed significantly higher 5-HT 1A -receptor binding in the basolateral amygdala, claustrum, and MRN than male WT mice. Female OE mice displayed higher [ 3 H]8eOHeDPAT binding in the CA2 region, parietal cortex, and hypothalamus than male OE mice (see Table 1 ).
Behavioural experiments
Untreated animals
In the FST, male OE mice spent significantly (p ¼ 0.030) more time trying to escape the glass cylinder than male WT mice pointing to an antidepressant-like behaviour (Fig. 2) . In contrast, female OE and WT mice showed comparable immobility times in the FST (p ¼ 0.307, Fig. 2 ).
Citalopram
Doses of 5.0 and 10.0 mg/kg citalopram decreased immobility in the FST in male WT mice (p ¼ 0.021; Fig. 3 ). However, this was accompanied by an increase in motor activity in the OFT at both doses (p < 0.001; Table 2 ). In male OE mice both doses of citalopram reduced immobility in the FST (p < 0.001; Fig. 3 ) without affecting motor activity in the OFT (p ¼ 0.137; Table 2 ). It has to be noted that the administration of 5.0 and 10.0 mg/kg citalopram induced in 4 out of 12 OE mice abnormal swimming behaviour, such as distorted swimming postures. These animals were excluded from the experiment. Both doses of citalopram had no influence on the ambulatory behaviour of male OE mice in the OFT.
Citalopram did not affect the escaping behaviour of female WT mice in the FST (p ¼ 0.133; Fig. 3 ). In contrast, in female OE mice 5.0 and 10.0 mg/kg citalopram reduced immobility in the FST (p ¼ 0.004; Fig. 3 ). Motor activity of female OE mice was not influenced by both doses of citalopram (p ¼ 0.805; Table 2 ). Similar to male OE mice, distorted swimming postures were also observed in transgenic females. Two out of 12 animals (5 mg/kg citalopram) and 5 out of 11 animals (10 mg/kg citalopram) were excluded from the experiments.
Reboxetine
Reboxetine had no effect on the swimming behaviour of either male OE (p ¼ 0.558) or male WT mice (p ¼ 0.103; Fig. 4) . In female WT mice 20 mg/kg reboxetine reduced immobility in the FST (p ¼ 0.029; Fig. 4 ). In the OFT, this dose caused hypoactivity in female WT mice (p ¼ 0.004; Table 2 ). Swimming behaviour of female OE mice remained unchanged by the treatment with reboxetine (p ¼ 0.253; Fig. 4) . 
Buspirone
At the highest dose (3.0 mg/kg), buspirone increased immobility in male WT mice in the FST (p < 0.001; Fig. 5 ). However, the same dose also decreased motor activity in the OFT (p ¼ 0.011; Table 2 ). Buspirone had no effect on the escape behaviour of male OE mice (p ¼ 0.901; Fig. 5 ) in the FST, but 3 mg/kg buspirone produced a similar distorted swimming behaviour in 9 out of 12 animals as described above for citalopram (the remaining animals are shown as single values in Fig. 5) .
In female WT mice, buspirone had no effect on the immobility in the FST (p ¼ 0.885; Fig. 5 ). Also, buspirone did not affect immobility of female OE mice (p ¼ 0.908; Fig. 5 ). Similar to male OE mice, 8 out of 12 female OE mice showed abnormal swimming behaviour when treated with 3.0 mg/kg buspirone. These animals were excluded from the experiment (the remaining animals are shown as single values in Fig. 5 ).
S 15535
S 15535 did not affect the immobility times of male WT (p ¼ 0.107), male OE (p ¼ 0.925), female WT (p ¼ 0.840) or female OE (p ¼ 0.092) mice in the used doses (15, 30, 60 mg/kg).
Discussion
Prevalence of depression is twice as high in women than in men, but women were found to have better outcomes following antidepressant treatments (Yang et al., 2011) . Despite this fact, several studies suggest that SSRI are more effective and better tolerated in women, so gender difference in antidepressant response still remains a highly discussed topic (see Keers et al., 2010) . On the one hand depressive disorders are associated with alterations of the 5-HT 1A -receptor and on the other hand gender differences in 5-HT 1A -receptor binding have been demonstrated in men and women (Jovanovic et al., 2008; Parsey et al., 2002) . Hence, we focused in this study on sex differences in 5-HT 1A -receptor overexpressing mice with regard to the 5-HT 1A -receptor density and to their response to antidepressants.
[ 3 H]8eOHeDPAT binding
In a previous gross receptor autoradiography study with [ 3 H] 8eOHeDPAT we revealed pronounced 5-HT 1A -receptor overexpression in the hippocampus and cortex of male transgenic mice (Bert et al., 2006) . In this study, we specified the brain regions, quantified the over-expressed receptors, and searched for sex differences. In OE mice we observed most intense labelling (5e9-fold) in three cortical sub-regions and in the CA3 region of the hippocampus independently from sex. The surplus expression occurs notably in the cortical layer III which contains a high number of pyramidal cells, but is also found in layers I and II. The cortical pattern of the over-expression in our transgenic mice resembles the 5-HT 1A -receptor distribution in the cortex of humans, where the receptor is also abundant in the outer cortical layers (Pazos et al., 1987) . We now observed that the surplus expression occurs also in the whole amygdala, as well as in the hypothalamus, lateral septum, claustrum, and tenia tecta of male as well as female OE mice. Most of these brain regions are thought to be part of the neuronal circuitry of depression (Maletic et al., 2007) . Again, as shown in our previous study (Bert et al., 2006) , 5-HT 1A -receptor over-expression is not apparent in the DRN or MRN of OE mice. Since there is no specific 5-HT 1A -receptor antibody available for electron microscopy in mice we were not able to determine the exact neuronal location of the surplus receptors. However, Jolimay et al. (2000) have shown that 5-HT 1A -receptors do not have the amino acid sequence which is necessary to be transported into the axon of serotonergic neurons. The genetic construct for generating our OE mice also does not exhibit this sequence (Kusserow et al., 2004) , which strongly implicates that the surplus 5-HT 1A -receptors are postsynaptically expressed. It could be argued that the over-expression is linked either to altered affinity or to abnormal coupling. In our earlier [ 3 H] 8eOHeDPAT binding study we did not observe a difference in the mean dissociation constant values K d between WT and OE mice of both genders (Bert et al., 2008) . Non-physiological coupling does not seem likely as we do see the expected pharmacological effects after systemic administration of 8eOHeDPAT in the OE mice (Bert et al., 2006 (Bert et al., , 2009 . This assumption is supported by a study using recombinant 5-HT 1A -receptors showing that an increased receptor:G-protein-ratio augments the potency and efficacy of full and partial agonists, respectively .
In the present study we revealed for the first time sex differences in the 5-HT 1A -receptor expression of OE mice. In female OE mice we detected significantly higher [
3 H]8eOHeDPAT labelling in three brain regions (parietal cortex, hypothalamus, and CA2 region of the hippocampus) than in male OE mice. WT mice also displayed sex differences in 5-HT 1A -receptor binding: Female WT mice showed higher 5-HT 1A -receptor labelling compared to male WT mice (basal/ lateral amygdala, claustrum, and MRN). There is few data on sex differences in mice available. Supporting our findings, in one study which used NMRI mice, higher [ 3 H]8eOHeDPAT binding was also detected in female mice in distinct brain areas compared to male NMRI mice (Schiller et al., 2006) . Sex differences in 5-HT 1A -receptor binding have been also described in humans with women showing higher (up to 39%) 5-HT 1A -receptor binding potential than men (e.g. Jovanovic et al., 2008; Parsey et al., 2002; Stein et al., 2008) .
Forced swim behaviour and effects of antidepressants 4.2.1. Male animals
The over-expression of postsynaptic 5-HT 1A -receptors in male transgenic mice is associated with an antidepressant-like phenotype in the FST, as indicated by lower immobility compared to male WT mice. This phenotype is not due to a generally higher motor activity of male OE mice as we have previously observed that male OE mice were even less active than male WT mice in an open field arena (Bert et al., 2006) . The antidepressant-like behaviour of male OE mice was confirmed by a hedonic response in a modified version of the sucrose preference-test, where male OE mice favoured a 2% sucrose solution over water (own observation). We suggest that the antidepressant-like phenotype can be attributed to the robust 5-HT 1A -receptors over-expression in the cortex and in the CA3 region. Complementary to our transgenic mice Richardson-Jones et al. (2009) generated mutant mice with a developmental suppression of postsynaptic 5-HT 1A -receptors. This suppression leads to increased depression-related behaviour in transgenic mice, which supports our finding that postsynaptic 5-HT 1A -receptors are involved in the pathophysiology of depression.
It has to be noted that the antidepressant-like phenotype of male OE mice was absent in the vehicle-treated group. We suggest that the injection procedure itself was a stressful event, which affected the depression-related behaviour in the FST. In several studies the injection procedure of saline has been shown to be a stressor and to elicit an anxiogenic effect (Lapin, 1995; Ryabinin et al., 1999) . Similar to our observation, Leggio et al. (2008) described that vehicle treatment can differently affect the behaviour of wild-type and mutant mice in the FST. In their study vehicletreated D 3 -receptor knockout mice showed no increase in immobility indicating a higher stress resistance in contrast to wild-type mice, which displayed higher immobility after vehicle treatment (Leggio et al., 2008) . In the case of our transgenic mice, male OE mice seemed to be more vulnerable to stress caused by the injection procedure, which could be explained by an increased activation of the long negative feedback mechanism mediated by postsynaptic 5-HT 1A -receptors (Hajos et al., 1999) . Forced swimming and vehicle injection were both found to increase 5-HT output in the raphe nuclei and forebrain structures (Adell et al., 1997) . Hence, it is possible that in our male OE mice the increased 5-HTrelease induced by the first stressor (saline injection) amplified the long negative feedback mechanism due to the higher number of postsynaptic receptors. As the second stressor (forced swimming) was submitted, a further increase of 5-HT release could not be achieved which has resulted in a depressant-like response of male OE mice.
The FST is considered to be a valid model for studying antidepressant drug effects following acute as well as chronic administration in rats and mice. Reduced immobility time has been interpreted as behavioural despair and points towards a potentially antidepressant drug effect (Cryan and Mombereau, 2004; Porsolt et al., 1978) . SSRIs like citalopram have been shown to decrease immobility time after acute treatment in mice (David et al., 2003; Sanchez and Meier, 1997) . It is conceivable that motor stimulant effects may contribute to the antidepressant-like effect of citalopram in the FST, as both drug effects may overlap. In male WT mice citalopram reduced immobility in the FST, but both effective doses were also shown to induce hyperactivity in the OFT. Only in male OE mice a clear-cut antidepressant effect of citalopram without any interference with motor activity was observed, suggesting a pronounced effect of citalopram in transgenic mice. This enhanced response of transgenic mice argues for an involvement of postsynaptic 5-HT 1A -receptors in the efficacy of citalopram.
Several studies show that citalopram induces hyperlocomotion in mice (Crowley et al., 2005; David et al., 2003) . By employing various antagonists at different 5-HT-receptors Millan et al. (2003) were able to relate citalopram induced hyperactivity to the activation of 5-HT 1B -and 5-HT 2A -receptors, but not of 5-HT 1A -receptors. However, they used the 5-HT 1A -antagonist WAY-100635 which binds to both, 5-HT 1A -auto-and -heteroreceptors. Since in our study the 5-HT 1A -receptor over-expression in corticolimbic areas counteracted the motor stimulant effects of citalopram in the OFT and since citalopram produced distorted swimming behaviour in some OE mice in the FST we suggest that postsynaptic 5-HT 1A -receptors are also involved in the locomotor effects of citalopram.
Reboxetine is a potent and selective NARI with weak additional binding properties (Wong et al., 2000) . It was shown that reboxetine has a clear antidepressant effect after acute treatment in the murine FST (Millan et al., 2001; Nielsen et al., 2004) . Due to its mechanism of action we expected a similar response to reboxetine in male WT and male OE mice. However, in our study reboxetine did not affect immobility of male WT and male OE mice in the FST. Our observation is supported by the finding of Andreasen et al. (2009a; 2009b) which repeatedly showed that high doses (20 and 30 mg/kg) of reboxetine did not alter swimming behaviour of mice in the FST. Other studies observed that the antidepressant effect of reboxetine appeared only when administered in high doses (Cryan et al., 2005a; Millan et al., 2001; Nielsen et al., 2004; Wong et al., 2000) . Although we increased the dose up to 40 mg/kg, reboxetine failed to decrease immobility in male mice of both genotypes. However, the response to reboxetine seems to depend on the gender as in our study reboxetine induced an antidepressant-like response in female WT mice.
The desensitisation of presynaptic 5-HT 1A -receptors seems to be a key mechanism in the pharmacotherapy of depression when 5-HT 1A -receptor agonists are combined with SSRIs (see reviews by Blier and Ward (2003) and Celada et al. (2004) ). It has also been discussed that direct activation of postsynaptic 5-HT 1A -receptors ameliorates antidepressant therapy (see Savitz et al. (2009) for review). In clinical practice only partial 5-HT 1A -receptor agonists like gepirone, ipsapirone, and buspirone, which possess only weak antidepressant properties, are used (McGrath et al., 1994; Robinson et al., 1990; Stahl et al., 1998) . One reason for the attenuated clinical efficacy of partial 5-HT 1A -receptor agonists could be that they exert only a weak agonistic effect at postsynaptic 5-HT 1A -receptor sites because of the lack of receptor reserve in serotonergic projection areas. We expected that OE mice would show a more pronounced response to the partial agonist buspirone compared to WT mice. This is based on our assumption that surplus 5-HT 1A -receptors lead to an artificial postsynaptic receptor reserve where partial agonists would exhibit full agonist effects. However, buspirone increased immobility in male WT mice accompanied by decreased ambulatory activity in the OFT. The "depression-like" response to buspirone in the FST might by a result of a general hypomotor effect. In most male OE mice the same dose of buspirone caused abnormal swimming behaviour. It is conceivable that these severe alterations of motor function surmounted a potential antidepressant-like activity of buspirone in the FST. We conclude that these motor disturbances are mediated by postsynaptic 5-HT 1A -receptors. This is supported by our previous finding that the full 5-HT 1A -receptor agonist 8eOHeDPAT provoked an exaggerated response in OE mice, apparent as decreased locomotor activity in the OFT and as a pronounced serotonin-syndrome already at low doses (Bert et al., 2006) .
In comparison to buspirone the partial 5-HT 1A -receptor agonist S 15535 has a lower intrinsic activity (about 25e30% vs. 62% for buspirone) and shows higher 5-HT 1A -receptor occupancy at postsynaptic than at presynaptic sites (Newman-Tancredi et al., 1998a , 1998b . Hence, S 15535 is thought to be a functional antagonist at postsynaptic sites, whereas it acts rather like an agonist at presynaptic sites due to the high receptor reserve in the raphe nuclei (Millan et al., 1994) . In our experiments, S 15535 failed to alter immobility time of male WT and OE mice in the FST. This result matches the findings from two other studies where the acute administration of S 15535 did not affect immobility time of either rats or mice (Bourin et al.,1998 ). We did not observe an influence of S 15535 on motor functions of transgenic mice as we have seen after buspirone or 8eOHeDPAT (Bert et al., 2006) . We assume that S 15535 is barely able to stimulate the over-expressed postsynaptic 5-HT 1A -receptor sites due to its low intrinsic activity.
Female mice
In contrast to male OE mice we observed no antidepressant-like phenotype in untreated female OE mice. This was surprising as female mice show a similar degree of 5-HT 1A -receptor over-expression and in three brain regions (parietal cortex, CA2, and hypothalamus) even to higher extent than male OE mice. A reason for the absence of an antidepressant-like phenotype in female OE mice could be the sex difference in 5-HT 1A -receptor expression in the parietal cortex, CA2, and hypothalamus of OE mice. In these regions 5-HT 1A -receptors coexist with oestrogen receptors (Weiser et al., 2008) and it is possible that these two receptor types closely interact.
Only in female OE mice, but not in female WT mice, both doses of citalopram reduced immobility time similar to males indicating a clear-cut antidepressant effect without affecting locomotor activity in the OFT. However, some female OE mice also showed distorted swimming behaviour. This strengthens our observations in male OE mice and confirms that the corticolimbic over-expression of 5-HT 1A -receptors contributes on the one hand to the antidepressant and on the other hand to the motor effect of citalopram.
In contrast to male WT mice, the dose of 20 mg/kg reboxetine was sufficient to produce an antidepressant-like effect in female WT mice. This effect appeared despite the hypolocomotor effect in the OFT. To our knowledge there is no report in literature on sex differences of reboxetine effects in laboratory rodents. The sex differences in the effects of reboxetine in our study are supported by clinical findings of Khan et al. (2005) who reported a trend for a higher responsiveness towards NARIs in depressed women compared to depressed men.
Similar to males, the partial 5-HT 1A -receptor agonist buspirone had no antidepressant effect in female WT and OE mice. We also observed abnormal swimming behaviour after the administration of the highest dose of buspirone in female OE mice as described for male OE mice. S 15535 also did not evoke an antidepressant response in female WT and OE mice, which coincides with our findings gained in male WT and OE mice.
Summarising, our data suggest that the postsynaptic 5-HT 1A -receptor is still a promising target for the therapy of depression. This is highlighted by the development of the highly selective postsynaptic 5-HT 1A -receptor agonist F15599 that yields a good antidepressant-like profile in rats . The results also indicate that the observed aberrant motor effects are mediated by postsynaptic 5-HT 1A -receptors and may contribute to unwanted side effects.
Conclusion
The detailed quantitative receptor autoradiography study with [ 3 H]8eOHeDPAT revealed a pronounced 5-HT 1A -receptor overexpression in various corticolimbic areas in male and female transgenic mice. Sex differences in the expression pattern were seen in both genotypes with females displaying generally a higher 5-HT 1A -receptor density than male mice. The selective overexpression of postsynaptic 5-HT 1A -receptors is associated with a clear-cut antidepressant response to the SSRI citalopram, but not to the NARI reboxetine. However, for all drug treatments sex differences were relevant for the outcome of the antidepressantlike drug effects. Though further pharmacological analysis is required, these data provide novel support for the role of postsynaptic 5-HT 1A -receptors in the antidepressant actions of SSRIs and unwanted motor side effects.
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